Transcatheter Tricuspid Interventions: Past, Present, and Future

Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis independent of all other variables. Surgical treatment for TR h...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Methodist DeBakey cardiovascular journal Ročník 19; číslo 3; s. 57 - 66
Hlavní autori: Barker, Colin M., Goel, Kashish
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Ubiquity Press Ltd 16.05.2023
Houston Methodist DeBakey Heart & Vascular Center
Predmet:
Cardiac Catheterization
Heart Valve Prosthesis Implantation
Humans
Review
Treatment Outcome
tricuspid regurgitation
Tricuspid Valve - diagnostic imaging
Tricuspid Valve - surgery
Tricuspid Valve Insufficiency - diagnostic imaging
Tricuspid Valve Insufficiency - surgery
tricuspid valve: transcatheter tricuspid valve repair
ttvr
tricuspid regurgitation
tricuspid valve: transcatheter tricuspid valve repair
TTVR
ISSN:1947-6108, 1947-6094, 1947-6108
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis independent of all other variables. Surgical treatment for TR has mostly been limited to patients undergoing concomitant left-sided cardiac surgery. The results and durability of surgical repair or replacement are not well defined. For patients with significant and symptomatic TR, transcatheter techniques would be beneficial, but these techniques and devices have been slow to develop. Much of the delay is a result of neglect and challenges in defining the symptoms associated with TR. In addition, the anatomic and physiological aspects of the tricuspid valve apparatus present unique challenges. Several devices and techniques are in various phases of clinical investigation. This review highlights the current landscape of transcatheter tricuspid interventions and future opportunities. It is imminent that these therapies become commercially available and widely adopted to have a significant positive impact on millions of patients that have been neglected.
Bibliografia:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1947-6108
1947-6094
1947-6108
DOI:10.14797/mdcvj.1250